Biosimilar switching maintains disease control in stable ankylosing spondylitis patients
Cheaper Arthritis Drugs Work Just as Well
This structured narrative review of patients with stable ankylosing spondylitis found that switching from reference biologics to biosimilars…
Switching to cheaper arthritis drugs keeps patients just as healthy while cutting treatment costs in half without losing results.
Infliximab in IVIG-resistant Kawasaki disease with cholestatic hepatitis: case report
Can a new drug stop heart damage in Kawasaki disease when standard treatments fail?
A case report describes a 2-year-old Han Chinese male with IVIG-resistant Kawasaki disease and cholestatic hepatitis treated with infliximab…
In a two-year-old boy with Kawasaki disease, the drug infliximab quickly stopped his fever and liver trouble, yet his heart artery damage ke…